Neutrophils contribute to the measles virus-induced antitumor effect: Enhancement by granulocyte macrophage colony-stimulating factor expression

Cancer Research

Volumn 63, Issue 19, 2003, Pages 6463-6468

  Grote, Deanna ^a   Cattaneo, Roberto ^a   Fielding, Adele K ^a,b  

^a MAYO CLINIC   (United States)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MATRIX PROTEIN; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; VIRUS HEMAGGLUTININ; VIRUS PHOSPHOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER REGRESSION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; LYMPHATIC SYSTEM TUMOR; MACROPHAGE; MEASLES VIRUS; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE; ULTRAVIOLET IRRADIATION; VIROGENESIS; VIRUS NUCLEOCAPSID; VIRUS REPLICATION;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD46; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; LYMPHOMA; MEASLES VIRUS; MEMBRANE GLYCOPROTEINS; MICE; MICE, SCID; MICE, TRANSGENIC; NEUTROPHILS; TRANSCRIPTION, GENETIC; VERO CELLS; VIRUS REPLICATION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0141953995     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Di Carlo, E., Forni, G., Lollini, P., Colombo, M. P., Modesti, A., and Musiani, P. The intriguing role of polymorphonuclear neutrophils in antitumor reactions. Blood, 97: 339-345, 2001.
2. Lozupone, F., Luciani, F., Venditti, M., Rivoltini, L., Pupa, S., Parmiani, G., Belardelli, F., and Fais, S. Murine granulocytes control human tumor growth in SCID mice. Int. J. Cancer, 87: 569-573, 2000.
3. Grote, D., Russell, S. J., Cornu, T., Cattaneo, R., Vile, R. G., Poland, G., and Fielding, A. K. Live attenuated measles virus induces regression of human lymphoma xenografts in immunodeficient mice. Blood, 97: 3746-3754, 2001.
4. Peng, K-W., TenEyck, C. J., Galanis, E., Kalli, K. R., Hartmann, L. C., and Russell, S. J. Intraperitoneal therapy of ovarian cancer using an engineered measles virus. Cancer Res., 62: 4656-4662, 2002.
5. Peng, K. W., Ahmann, G. J., Pham, L., Greipp, P. R., Cattaneo, R., and Russell, S. J. Systemic therapy of myeloma xenografts by an attenuated measles virus. Blood, 98: 2002-2007, 2001.
6. Quesniaux, V., and Jones, T. Granulocyte-macrophage colony stimulating factor. In: A. Thomson (ed.), The Cytokine Handbook, pp. 637-670 Burlington, MA: Academic Press Ltd., 1998.
7. Yong, K. L., and Linch, D. C. Granulocyte-macrophage-colony-stimulating factor differentially regulates neutrophil migration across IL-1-activated and nonactivated human endothelium. J. Immunol., 150: 2449-2456, 1993.
8. Jones, T. C. The effect of granulocyte-macrophage colony stimulating factor (rGM-CSF) on macrophage function in microbial disease. Med. Oncol., 13: 141-147, 1996.
9. Richard, C., Baro, J., Bello-Fernandez, C., Hermida, G., Calavia, J., Olalla, I., Alsar, M. J., Loyola, I., Cuadrado, M. A., Iriondo, A., et al. Recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF) administration after autologous bone marrow transplantation for acute myeloblastic leukemia enhances activated killer cell function and may diminish leukemic relapse. Bone Marrow Transplant., 15: 721-726, 1995.
10. Cattaneo, R., Rebmann, G., Schmid, A., Baczko, K., ter Meulen, V., and Billeter, M. A. Altered transcription of a defective measles virus genome derived from a diseased human brain. EMBO J., 6: 681-688, 1987.
11. Radecke, F., Spielhofer, P., Schneider, H., Kaelin, K., Huber, M., Dotsch, C., Christiansen, G., and Billeter, M. A. Rescue of measles viruses from cloned DNA. EMBO J., 14: 5773-5784, 1995.
12. von Messling, V., Zimmer, G., Herrler, G., Haas, L., and Cattaneo, R. The hemagglutinin of canine distemper virus determines tropism and cytopathogenicity. J. Virol., 75: 6418-6427, 2001.
13. Kärber, G. Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche. Arch. Exp. Pathol. Pharmakol., 162: 480-483, 1931.
14. Mrkic, B., Pavlovic, J., Rulicke, T., Volpe, P., Buchholz, C. J., Hourcade, D., Atkinson, J. P., Aguzzi, A., and Cattaneo, R. Measles virus spread and pathogenesis in genetically modified mice. J. Virol., 72: 7420-7427, 1998.
15. Mrkic, B., Odermatt, B., Klein, M. A., Billeter, M. A., Pavlovic, J., and Cattaneo, R. Lymphatic dissemination and comparative pathology of recombinant measles viruses in genetically modified mice. J. Virol., 74: 1364-1372, 2000.
16. Roscic-Mrkic, B., Schwendener, R., Odermatt, B., Zuniga, A., Pavlovic, J., Billeter, M. A., and Cattaneo, R. The roles of macrophages in measles virus infection of genetically modified mice. J. Virol., 75: 3343-3351, 2001.
17. Kasai, S., Fujimoto, S., Nitta, K., Baba, H., and Kunimoto, T. Antitumor activity of polymorphonuclear leukocytes activated by a β-1,3-D-glucan. J. Pharmacobiodyn., 14: 519-525, 1991.
18. Fujii, Y., Kimura, S., Arai, S., and Sendo, F. In vivo antitumor effect of lymphokine-activated rodent polymorphonuclear leukocytes. Cancer Res., 47: 6000-6005, 1987.
19. Yang, K. D., Stone, R. M., Lee, C. S., Chao, T. Y., Cheng, S. N., and Shaio, M. F. Effect of picibanil (OK432) on neutrophil-mediated antitumor activity: implication of monocyte-derived neutrophil-activating factors. Cancer Immunol. Immunother., 35: 277-282, 1992.
20. Colombo, M. P., Lombardi, L., Stoppacciaro, A., Melani, C., Parenza, M., Bottazzi, B., and Parmiani, G. Granulocyte colony-stimulating factor (G-CSF) gene transduction in murine adenocarcinoma drives neutrophil-mediated tumor inhibition in vivo. Neutrophils discriminate between G-CSF-producing and G-CSF-nonproducing tumor cells. J. Immunol., 149: 113-119, 1992.
21. Behrens, C. K., Igney, F. H., Arnold, B., Moller, P., and Krammer, P. H. CD95 ligand-expressing tumors are rejected in anti-tumor TCR transgenic perforin knockout mice. J. Immunol., 166: 3240-3247, 2001.
22. Morikawa, K., Kamegaya, S., Yamazaki, M., and Mizuno, D. Hydrogen peroxide as a tumoricidal mediator of murine polymorphonuclear leukocytes induced by a linear β-1,3-D-glucan and some other immunomodulators. Cancer Res., 45: 3482-3486, 1985.
23. Pericle, F., Kirken, R. A., Epling-Burnette, P. K., Blanchard, D. K., and Djeu, J. Y. Direct killing of interleukin-2-transfected tumor cells by human neutrophils. Int. J. Cancer, 66: 367-373, 1996.
24. Learn, D. B., and Thomas, E. L. Inhibition of tumor cell glutamine uptake by isolated neutrophils. J. Clin. Invest., 82: 789-796, 1988.
25. Newsholme, E. A., Crabtree, B., and Ardawi, M. S. Glutamine metabolism in lymphocytes: its biochemical, physiological and clinical importance. Q. J. Exp. Physiol., 70: 473-489, 1985.
26. Dranoff, G., Jaffee, E., Lazenby, A., Golumbek, P., Levitsky, H., Brose, K., Jackson, V., Hamada, H., Pardoll, D., and Mulligan, R. C. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc. Natl. Acad. Sci. USA, 90: 3539-3543, 1993.